Factor IV – The ‘Coagulation Factor’ That Isn’t a Protein – ICHCC
Iranian Comprehensive Hemophilia Care Center (ICHCC) shared a post on LinkedIn:
“Factor IV: The ‘Coagulation Factor’ That Isn’t a Protein
Did you know that Factor IV is part of the historical coagulation factor numbering system, but unlike Factors VIII or IX, it is not a protein?
What is Factor IV?
Factor IV is Calcium (Ca²⁺)
Calcium is an essential cofactor in multiple steps of the coagulation cascade.
It helps coagulation factors assemble on negatively charged phospholipid surfaces and is particularly important for the formation and function of several coagulation complexes.
Where Does Calcium Act?
Ca²⁺ is essential for important coagulation complexes, including:
- Tenase complex
- Prothrombinase complex
For example:
Factor Xa, Factor Va, calcium ions, and phospholipids combine to generate thrombin.
Then:
Thrombin leads to Fibrin formation
Without adequate calcium availability, these reactions cannot proceed normally.
Why Is Calcium Important in Coagulation Testing?
Why do we collect coagulation samples in Sodium citrate tubes?
Because citrate chelates ionized calcium, temporarily preventing clot formation in the blood sample.
When performing:
- PT
- aPTT
the laboratory adds calcium back to the plasma to initiate the coagulation reaction.
So, conceptually:
- Citrate removes available Ca²⁺
- Laboratory adds Ca²⁺ back
- Coagulation can then be measured
Is There a ‘Factor IV Deficiency’?
Not in the same sense as Factor VIII or Factor IX deficiency.
There is no recognized inherited Factor IV deficiency disorder comparable to classic hemophilia.
Severe hypocalcemia can affect hemostasis, particularly in critically ill patients, but it does not typically present as a classic inherited bleeding disorder.
Clinical Pearl
Factor IV is calcium – not a coagulation protein.
It is a fascinating reminder that the historical coagulation factor numbering system does not represent a list of proteins alone.
Not every ‘coagulation factor’ is a protein.”
Other posts about Iranian Comprehensive Hemophilia Care Center on Hemostasis Today.
-
Oct 13, 2026, 15:21Renel Tique: Advancing Hemophilia Care Through Global Collaboration and Clinical Innovation
-
Oct 13, 2026, 15:08Anastasia Chatzistamati: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome
-
Oct 13, 2026, 15:08Yousma Khan: Hematology Practical Series Day 11 Reticulocyte Count and Its Role in Anemia Diagnosis
-
Oct 13, 2026, 14:56Manal Rayyan: Multidisciplinary Collaboration in Rare Bleeding Disorders – Reflections from Abu Dhabi
-
Oct 13, 2026, 14:54Kalyan Roy: Understanding Blood Transfusion Sets for Safe Clinical Administration
-
Oct 13, 2026, 14:52Chedia Aroua: When Pharmacokinetics Meets Geophysics – Finding Unlikely Connections in Hemophilia Care
-
Oct 13, 2026, 14:47Mehmet Can Uğur: Honored by the Presence and Mentorship of Prof. Dargaud at Our Congress
-
Oct 13, 2026, 14:40Cheryl Loetscher: This Day in Drug Discovery – Wakix and H3 Receptor Inverse Agonism in Narcolepsy
-
Oct 13, 2026, 14:30Thirunavukkarasu Angappan: FVIII vs. FIX Expressive Durability – Key Lessons from GENEr8-1 and HOPE-B Long-Term Data